Stroke-heart syndrome: mechanisms, risk factors, and adverse cardiovascular events.

Competing Interests: Conflict of interest: B.J.R.B. has received research funding from Bristol Myers Squibb (BMS)/Pfizer. S.L.H. has received funding from BMS. D.A.L. has received investigator-initiated educational grants from Bristol Myers Squibb (BMS) and Pfizer; been a speaker for Boehringer Ingelheim, Bayer, and BMS/Pfizer and consulted for Boehringer Ingelheim, Bayer, and BMS/Pfizer; all outside the submitted work. G.Y.H.L.: consultant and speaker for BMS/Pfizer, Medtronic, Boehringer Ingelheim, and Daiichi-Sankyo. No fees are directly received personally.